The abstract is read at the publisher; the summary is JClub's.
A young woman with acute myeloid leukaemia developed calciphylaxis complicated by a pan-resistant New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa isolate that was domestically acquired in the USA.
- Why it matters: Calciphylaxis is rare and potentially fatal, and pan-resistant NDM-1 Pseudomonas aeruginosa infections add major diagnostic and treatment challenges, especially when acquisition is atypical.
- What they did: Clinicians managed ulcerated calciphylaxis lesions superinfected with an early domestically acquired NDM-1-producing isolate using calciphylaxis-directed care plus bacteriophage therapy and the first USA use of cefepime-zidebactam.
- The result: The case demonstrates diagnostic complexity in atypical populations and suggests that combining cefepime-zidebactam with phage therapy may support favourable outcomes in this rare condition.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.